SURF - Surface Oncology +5.8% as Wedbush sees 126% upside August, 27 2020 09:56 PM Surface Oncology Inc. Surface Oncology (NASDAQ:SURF) wrapped up after-hours trading up 5.8% after drawing a new Outperform rating from Wedbush.More news on: Surface Oncology, Inc., Healthcare stocks news, Stocks on the move, Read more ...